Tassin la Demi Lune, France

Patrick Léon

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Léon. Retrieved from https://idiyas.com/inventor/patrick-landeacuteon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick Léon

Introduction

Patrick Léon is a notable inventor based in Tassin la Demi Lune, France. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of camptothecin and its derivatives. His work has implications for cancer treatment and showcases the importance of innovative processes in drug development.

Latest Patents

Patrick Léon holds a patent for the "Preparation of camptothecin and of its derivatives." This invention relates to a novel process for the preparation of camptothecin through convergent synthesis, starting from a 3-(aminomethyl)quinoline derivative and 5-hydroxy-5-ethyl-6-oxo-5,6-dihydropyrancarboxylic acid. The patent also covers the intermediates obtained during this process. He has 1 patent to his name.

Career Highlights

Patrick Léon is associated with Aventis Pharma S.A., a prominent company in the pharmaceutical industry. His work at Aventis has allowed him to focus on innovative drug development and contribute to advancements in medical science.

Collaborations

Throughout his career, Patrick has collaborated with talented individuals such as Stéphanie Garçon and Yves Génisson. These collaborations have enriched his research and contributed to the success of his inventions.

Conclusion

Patrick Léon's contributions to the field of pharmaceuticals through his innovative processes highlight the critical role of inventors in advancing medical treatments. His work continues to inspire future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…